Protein G Resin (Affinity/Chromatography) Principles, Parameters, and Applications｜Guide to Choosing Recombinant Protein G Resin

In the fields of biopharmaceuticals, antibody engineering, scientific research diagnostics, and immunology, affinity chromatography is the core process for antibody purification. Protein G resin, as a key affinity chromatography medium, has become an essential material to complement the shortcomings of Protein A purification systems due to its broader antibody-binding capability. Compared to Protein A, Protein G affinity resin has a wider binding spectrum for multi-species, multi-subtype IgG antibodies, making it widely suitable for fine applications such as research-grade antibody purification, multi-species antibody preparation, and purification of diagnostic reagent raw materials.

With the standardization of biological experiments and the push for domestic production of biological reagents, recombinant Protein G resin, which offers stable performance, controlled batch consistency, and broad adaptability for purification scenarios, is gradually replacing traditional natural resins and becoming mainstream in the industry. As a precisely targeted chromatography medium, the performance stability, binding specificity, gentle elution conditions, and reusability of Protein G resin directly determine antibody product purity, activity retention, and experimental reproducibility.

I. What is Protein G?

 Protein G

Protein G is a protein isolated from the cell surface of group C or G streptococci, similar to Protein A found in Staphylococcus aureus. It primarily binds antibodies through interactions with the Fc region of immunoglobulin G (IgG).

Natural Protein G contains multiple IgG-binding domains (usually three tandem domains: B1, B2, and B3), as well as albumin-binding sites and cell wall anchoring regions. Commercial recombinant Protein G ligands are typically engineered versions that remove the albumin-binding and cell wall regions, keeping only the core IgG-binding domains. This reduces non-specific binding while improving the stability and purity of the ligand.

Compared to Protein A, Protein G’s main advantage is a broader antibody binding spectrum. The differences are specifically reflected in:

① More complete IgG subtype binding. Protein A has weak or no binding to human IgG3 and mouse IgG1, whereas Protein G can effectively bind these important antibody subtypes;

② Broader species coverage. Protein G binds more strongly to polyclonal antibodies from species like cattle, sheep, horse, and rat, which is particularly important for veterinary antibodies and polyclonal serum purification;

③ Lower non-specific binding. Recombinant Protein G, lacking the albumin and other non-specific binding regions, has lower background and higher purity of the final product;

④ Stronger affinity. Protein G can effectively bind subtypes that Protein A struggles with (like human IgG3 and mouse IgG1). However, the stronger binding often requires lower pH for elution, so acid-sensitive antibodies need careful assessment of elution conditions and immediate neutralization after elution.

It is these unique advantages that make Protein G chromatography resins irreplaceable in both research labs and industrial production.

II. Six Core Parameters of Protein G Affinity Media

1. Dynamic Binding Capacity (DBC)

Dynamic binding capacity is the key indicator of a medium's adsorption ability. It refers to the amount of target protein the medium can effectively bind under a certain flow rate and residence time. The industry standard is Q₁₀% (binding capacity when antibody breakthrough reaches 10% at 4–6 minutes of residence time). High-quality recombinant Protein G media typically have a DBC of 18–25 mg/mL for human IgG, and high-capacity products can exceed 30 mg/mL.

2. Chemical Stability and Alkali Resistance

Alkali resistance directly affects the life of the medium. In biopharmaceutical production, the medium needs to be cleaned in place (CIP) with NaOH after each use to remove residual proteins, endotoxins, and microbes. It’s worth noting that natural and ordinary recombinant Protein G are less alkali-resistant than Protein A. For traditional Protein G Sepharose products, recommended CIP conditions usually involve dilute acetic acid (0.1–0.5 M) or low-concentration NaOH (e.g., 15 mM) combined with a reducing agent, and they shouldn’t be exposed to high-concentration NaOH for long periods.

3. Ligand Leaching Rate

Leached ligands can get into the purified product, and pharmaceutical-grade antibodies require strict control of ligand residues. High-quality media typically use oriented coupling techniques (such as C-terminal cysteine thiol site-specific coupling) to ensure consistent ligand orientation for higher effective binding and to enhance the chemical stability of the coupling bond, reducing leaching.

4. Non-Specific Adsorption

Lower non-specific adsorption means cleaner samples and higher purity. Recombinant Protein G, having removed the albumin-binding region, has significantly lower non-specific adsorption compared to natural Protein G. Highly hydrophilic matrices (like highly cross-linked agarose) also help reduce non-specific adsorption.

5. Matrix Type and Particle Size

The matrix determines the medium’s mechanical strength, flow tolerance, and mass transfer efficiency. Agarose-based matrices are hydrophilic and widely used; highly cross-linked agarose withstands high pressure and is suitable for industrial scale; polymer matrices (PMMA/PS-DVB) have extremely high mechanical strength, ideal for continuous flow processes; magnetic beads are used for rapid purification of small samples and IP experiments. Particle sizes usually range from 20–150 μm — smaller beads mean higher column efficiency but higher backpressure.

6. Elution pH Range

Protein G has stronger affinity for most IgGs than Protein A, so elution pH is usually lower (around 2.5–3.5). However, for antibody subtypes with weak Protein A binding (such as mouse IgG1), Protein G allows milder elution conditions, which is gentler for acid-sensitive antibodies.

III. The Fourth Generation Evolution of Recombinant Protein G Ligands

From natural extraction to AI design, Protein G ligands have undergone four generations of technological leaps:

First Generation, Natural Extraction: Directly extracted natural Protein G from Streptococcus cultures; low yield, batch variability, high nonspecific binding, basically phased out now.

Second Generation, Recombinant Expression: Expressed recombinant Protein G in hosts like E. coli via genetic engineering; removed albumin-binding and cell wall anchoring domains, kept only the IgG-binding domain, significantly reducing nonspecific binding.

Third Generation, Engineered Modification: Further optimized recombinant ligands, including domain simplification (reducing redundancy, increasing ligand density), multi-domain tandem arrangement (increasing valency, enhancing loading), alkali resistance modification (replacing alkali-sensitive residues, extending lifespan), and specificity optimization (modifying binding interfaces to reduce nonspecific binding).

Fourth Generation, AI Design: Powered by AI protein large models, using structure prediction, mutation effect evaluation, and multi-objective optimization to quickly identify optimal mutation combinations in a huge sequence space, cutting traditional ligand development cycles from "years" to "months".

IV. Five Typical Application Scenarios and Selection Recommendations

1. Purification of Polyclonal Antibodies

Protein G binds well to IgG from a variety of species such as bovine, sheep, horse, rabbit, and rat, making it one of the top choices for purifying polyclonal antibodies.

Selection recommendation: Prefer high-capacity, alkali-resistant recombinant Protein G resins to balance efficiency and lifespan.

2. Purification of Specific Subtype Monoclonal Antibodies

For antibody subtypes with weak Protein A binding (like human IgG3 or mouse IgG1), Protein G often provides better purification results.

Selection recommendation: Choose the appropriate type after confirming the antibody subtype; for acid-sensitive antibodies, test recovery at different elution pH values.

3. Immunoprecipitation and Co-Immunoprecipitation (IP/Co-IP)

Protein G resins (especially magnetic beads) are widely used in IP and Co-IP experiments to capture antigen-antibody complexes from complex samples like cell lysates.

Selection recommendation: For small samples, Protein G magnetic beads are preferable; for large samples, agarose-based resins work better.

4. Purification of Antibody Fragments and Fusion Proteins

For fusion proteins or Fc-fusion drugs containing an Fc region, Protein G can also be used as a capture resin.

Selection recommendation: Confirm the Fc origin and subtype, and pay attention to steric effects impacting the binding capacity.

5. Complementary Option to Protein A

Protein G isn’t a replacement for Protein A, but rather a complement — when the target antibody binds weakly to Protein A (like human IgG3 or mouse IgG1) or the sample’s species isn’t within Protein A’s optimal range, Protein G is a better capture option. In research settings, both resins can be used in parallel, comparing recovery and purity to choose the best solution.

Selection recommendation: First judge based on antibody subtype and species source; if unsure, perform small-scale parallel screening with pre-packed columns.

V. AI Empowerment: A New Paradigm for Protein G Ligand Design

Traditional Protein G ligand modification relies heavily on expert experience and high-throughput screening. Developing an industrial-grade, high-performance ligand can take years and involve screening thousands of mutants, with very high trial-and-error costs. The maturity of AI protein design technology is fundamentally changing this landscape.

Precision-guided alkali resistance modification: AI analyzes the 3D structure and surface chemistry of ligands through large models, accurately identifying high-risk deamidation sites while evaluating the impact of mutations on structure and function, outputting the optimal mutation combinations in one go, greatly reducing the experimental workload.

Joint optimization of load and specificity: AI uses multi-objective optimization algorithms to find the best balance across multiple performance metrics like load, specificity, and alkali resistance, breaking the traditional bottleneck of "optimize one thing, compromise another."

Rapid iterative cycles of wet and dry experiments: AI design integrates with automated wet-lab experiments, creating a complete "design-validate-iterate" loop. According to 2026 WAIC public disclosures, this approach can compress the protein development cycle from 2–5 years to 2–6 months, boosting success rates from around 1% to about 30%.

Domestic practice: Matwings Mall AI-designed Protein G resins

 MatwingsVenus™ Online Shop

MatwingsVenus™ (Xiaowu™), a conversational protein research AI independently developed by Shanghai Matwings Technology Co., Ltd., is the first full-stack protein research platform in China centered around AI agents, integrating computational design with automated wet lab experiments. The platform leverages a protein sequence dataset of nearly 10 billion entries (including billions of functional labels) and a self-developed general protein design large model, incorporating over 200 design tools, more than 50 domain experts, and 30+ expert-tuned skills. Users can drive the entire research process simply by describing their goals in natural language.

Based on this platform, Matwings Technology has launched its own Protein G affinity chromatography resin series on the Matwings Mall, forming a complete affinity purification product line together with alkali-resistant/mild-elution Protein A, Protein L, VHH, and other supporting products. The AI-designed version is upgraded in four aspects: broader antibody binding spectrum (AI-optimized binding interface), lower nonspecific adsorption (optimized surface charge and hydrophilicity), enhanced alkali resistance (precise replacement of alkali-sensitive sites), and directed conjugation with low leaching (terminal site-specific conjugation design).

In addition to standard products, Matwings Mall also offers customized Protein G resin development services—targeted at special antibody subtypes, bispecific/ADC/Fc fusion proteins, and other personalized purification needs, resin can be designed from scratch based on the target structure, with full support from design to process validation.

VI. F.A.Q

Q1: How to choose between Protein G and Protein A?

A: For human IgG1/2/4 and mouse IgG2a, which are strong Protein A binders, prioritize Protein A; for human IgG3, mouse IgG1, or multi-species polyclonal antibodies, prioritize Protein G.

Q2: How many times can recombinant Protein G resins be reused?

A: Research-grade resins can typically be reused 5–10 times under mild conditions; industrial-grade alkali-resistant resins, with standard CIP operations, are usually reusable over 100 times (with 80% or more binding capacity retention as the standard).

Q3: What’s the difference between natural and recombinant Protein G?

A: Natural Protein G is directly extracted from streptococci and contains redundant regions like albumin-binding domains, resulting in high nonspecific adsorption and batch variability. Recombinant Protein G is expressed via genetic engineering, removing redundant regions, leading to low nonspecific adsorption, batch stability, and controllable performance, making it the mainstream choice on the market today.

VII. Conclusion

From the natural proteins on the surface of streptococci to genetically engineered recombinant ligands, and then to AI-designed high-performance variants, Protein G resins have undergone continuous evolution. Complementing the function of Protein A, Protein G holds an irreplaceable position in antibody purification thanks to its broader antibody binding spectrum, lower nonspecific adsorption, and more flexible engineering potential.

In the future, as AI protein design technology continues to advance, recombinant Protein G resins will keep upgrading toward higher capacity, stronger alkali resistance, better specificity, and more customized applications. Domestic AI protein design platforms like MatwingsVenus™ are injecting fresh momentum into this evolution.